Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M64.9Revenue $M6.2Net Margin (%)33.5Z-Score-8.4
Enterprise Value $M25.3EPS $0.2Operating Margin %128F-Score2
P/E(ttm))0Cash Flow Per Share $-1.4Pre-tax Margin (%)116Higher ROA y-yN
Price/Book6.710-y EBITDA Growth Rate %0Quick Ratio1.0Cash flow > EarningsN
Price/Sales05-y EBITDA Growth Rate %-12.6Current Ratio1.0Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-25.6Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-102.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M57.9ROI % (ttm)-76.6Gross Margin Increase y-yY

Gurus Latest Trades with AEZS

Number of guru portfolios checked: 84. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
AEZSJean-Marie Eveillard 2010-03-31 Sold Out $4.8 - $5.58
($4.98)
$ 1.11-78%Sold Out0
AEZSJean-Marie Eveillard 2009-12-31 Reduce$4.74 - $7.5
($6.12)
$ 1.11-82%Reduce -91.09%124,518
AEZSJean-Marie Eveillard 2009-09-30 Buy 0.02%$5.34 - $16.98
($9.72)
$ 1.11-89%New holding, 1397897 sh.1,397,897
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

AEZS is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


AEZS: Insider Buys/Sells

Click Here for All Insider Trades.

No Insider Trades Found!

Press Releases about AEZS :

    Quarterly/Annual Reports about AEZS:

      News about AEZS:

      Articles On GuruFocus.com
      Billionaires Hold Waning Biotechs 42% Off Oct 16 2013 
      Can Keryx Succeed Without Partnership? Apr 24 2012 
      Keryx Still Has High Potential from Zerenex Apr 12 2012 
      comment on AEZS Oct 26 2011 
      Opportunistic Coat-tailing Jan 05 2010 

      More From Other Websites
      Nasdaq stocks posting largest volume increases Oct 28 2014
      October 28, 2014 Aeterna Zentaris to Announce Third Quarter 2014 Financial and Operating Results on... Oct 28 2014
      Aeterna Zentaris to Announce Third Quarter 2014 Financial and Operating Results on November 4, 2014 Oct 28 2014
      Aeterna Zentaris to Announce Third Quarter 2014 Financial and Operating Results on November 4, 2014 Oct 28 2014
      October 27, 2014 Aeterna Zentaris Announces Formal Implementation of its Sales Force In Support of... Oct 27 2014
      Aeterna Zentaris Announces Formal Implementation of its Sales Force In Support of Selling ASCEND's... Oct 27 2014
      Aeterna Zentaris Announces Formal Implementation of its Sales Force In Support of Selling ASCEND's... Oct 27 2014
      Aeterna Zentaris Appoints Phil Theodore as Chief Administrative Officer, General Counsel and... Oct 07 2014
      Aeterna Zentaris Appoints Phil Theodore as Chief Administrative Officer, General Counsel and... Oct 07 2014
      Aeterna Zentaris to Present at Upcoming Rodman & Renshaw Annual Global Investment Conference in New... Sep 02 2014
      Aeterna Zentaris to Present at Upcoming Rodman & Renshaw Annual Global Investment Conference in New... Sep 02 2014
      4 Stocks Under $10 to Trade Now Aug 15 2014
      Aeterna Zentaris Reports Second Quarter 2014 Financial and Operating Results Aug 07 2014
      Aeterna Zentaris Reports Second Quarter 2014 Financial and Operating Results Aug 07 2014
      Aeterna Zentaris to Present at Upcoming Canaccord Genuity 34th Annual Global Growth Conference in... Aug 06 2014
      Aeterna Zentaris to Present at Upcoming Canaccord Genuity 34th Annual Global Growth Conference in... Aug 06 2014
      Aeterna Zentaris and ASCEND Therapeutics Sign Co-Promotion Agreement for U.S. Market Aug 05 2014
      Aeterna Zentaris and ASCEND Therapeutics Sign Co-Promotion Agreement for U.S. Market Aug 05 2014
      Aeterna Zentaris to Announce Second Quarter 2014 Financial and Operating Results on August 7, 2014 Jul 31 2014
      12 Analyst Stocks to Buy Under $10 With Huge Potential Upside Jul 19 2014

      Add Notes, Comments

      If you want to ask a question, or report a bug, please create a support ticket.

      User Comments

      No comment yet
      Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
      GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
      Free 7-day Trial
      FEEDBACK